logo

SMITH & NE(NYSE:SNN)
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
# Employees: 0
Address: 15 Adam Street,,Lo,
Phone: WC2N 6LA
Fax: 44 020 7401 7646
Website:
Email: 44 020 7930 3353
Sector: Medical
Industry: MED PRODUCTS
Executive Officers
Secretary (Christopher J. O???Donnell)
Dir. (Peter Hooley)
Dir. ()
Dividend
Ex-Dividend Date: 10/14/2009
Annual Dividend: $0.68
Current Dividend Yield: $1.43
Dividend Paid (3 months): $0.27
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2008
Next Earnings Date(Expected): 11/6/2009
Mean EPS (Next Qtr): $0.94
Mean EPS (Year): $3.09
Mean Estimate(Long Term): $11.00
P/E Ratio(Based on EPS estimate): 15.400
Number of Estimates: 7
Shares Performance
Period SNN Compare to S&P
YTD 47.15 % 21.79 %
4 Weeks 7.15 % 5.99 %
12 Weeks 10.87 % 4.53 %
Shares Information
Analyst Coverage: Y
Avg Volume: 82692
Shares Outstanding: 176M
Market Cap: $8.41B
52 Week High: $48.67
52 Week Low: $30.39
P/E Ratio: 16.800
PEG Ratio: 1.400
Split: On 12/16/2003 SNN split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 18.46 %
EPS Growth in Last Year: 10.00 %
Sales Growth in Last Quarter: -1.19 %
Sales Growth in Last Quarter: -1.61 %
Financials
Qtr Book Value: $4.19
Cash Flow/Share: $10.76
Change in Payout Ratio: -0.010
Price/Sales: 2.290
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia